key: cord-0774387-y29ynj63
authors: Chaintoutis, Serafeim C.; Siarkou, Victoria I.; Mylonakis, Mathios E.; Kazakos, George M.; Skeva, Panagiota‐Nefeli; Bampali, Maria; Dimitriou, Marios; Dovrolis, Nikolaos; Polizopoulou, Zoe S.; Karakasiliotis, Ioannis; Dovas, Chrysostomos I.
title: Limited cross‐species transmission and absence of mutations associated with SARS‐CoV‐2 adaptation in cats: A case study of infection in a small household setting
date: 2021-05-16
journal: Transbound Emerg Dis
DOI: 10.1111/tbed.14132
sha: d67e848a8bbdfe17a24835f1e854dbe7486c4756
doc_id: 774387
cord_uid: y29ynj63

In the present study, the course of SARS‐CoV‐2 natural infection in two asymptomatic cats, which were negative for immunosuppressive retroviral infections, is investigated. The source of the virus for the cats was their COVID‐19‐affected owner, with whom they were in continuous proximity in a small household setting. The owner's signs included fatigue, sneezing, anosmia and loss of taste, and diagnosis was confirmed 4 days after symptom onset. Oropharyngeal and faecal swabs were collected from the cats, to investigate the course of SARS‐CoV‐2 RNA concentrations, as well as the directionality of the chain of virus transmission. Both infected cats were real‐time RT‐PCR‐positive on various time‐points. Pharyngeal shedding of at least 6 days was observed in them, with high SARS‐CoV‐2 titres (> 7 Log(10) copies/swab) on the first sampling time‐point, that is, 7 days after the onset of owner's clinical signs. In one cat, after the initial decline, slightly increasing virus titres were measured 3 to 6 days after the first real‐time RT‐PCR‐positive swab. Serological testing of this cat revealed absence of seroconversion. The course of viral RNA concentrations in the faecal swabs of the other cat was similar to that in its pharynx. The detected SARS‐CoV‐2 strains, from both infected cats and their owner, underwent whole‐genome sequencing, revealing the absence of emergence of cross‐species adaptive mutations in cats. The results support the notion that human SARS‐CoV‐2 strains are relatively well‐adapted to cats. It is still unclear whether asymptomatic animals could play a role in COVID‐19 epidemiology, in case of interaction with naïve animals and/or people. Our findings highlight difficulties in SARS‐CoV‐2 transmission to cats, as neither the two infected cats nor their owner was able to transmit the virus to a third cat living in the same small flat, despite their very close contact during the days corresponding to high virus shedding.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel member of the Coronaviridae family (Betacoronavirus genus), responsible for the coronavirus disease 2019 pandemic in humans, for which a spill-over from wild animals is most likely (Boni et al., 2020; Dhama et al., 2020; Malik et al., 2020) .

This virus possesses a single-stranded, positive-sense RNA of ~30 kb that encodes approximately 9,860 amino-acids. Two open reading frames (ORFs), ORF1a and ORF1b, located at the 5' terminus of the genome encode 16 non-structural proteins (NSPs). Four structural proteins [i.e. envelope (E), membrane (M), nucleocapsid (N) and spike (S) proteins] as well as several accessory proteins are produced through the expression of subgenomic mRNAs (Chan et al., 2020; Kim et al., 2020) .

The S protein mediates receptor binding on target cells and determines host tropism. Similarly to SARS-CoV-1, the receptor utilized by SARS-CoV-2 to enter target cells is the angiotensin-converting enzyme 2 (ACE2) . It has been identified that, besides humans, the receptor-binding domain of the virus recognizes ACE2 from various animal species, including cats (Luan et al., 2020; Wan et al., 2020) . Consequently, cats exposed to SARS-CoV-2 through contact with infected people, either asymptomatic virus carriers, or patients, can be affected, thus resulting in human-to-animal virus transmission, that is, a reverse zoonosis (Segalés et al., 2020) . It is noteworthy, meanwhile, that coronaviruses have adapted species by species over relatively short to long periods of time, in human and animals. Domestic and wild cats are the hosts of feline coronavirus (FCoV), a highly prevalent virus with worldwide distribution, that is classified within the Alphacoronavirus 1 species (Alphacoronavirus genus), along with common cold-causing coronaviruses of humans (Drechsler et al., 2011) .

The capability of SARS-CoV-2 to infect cats has been indicated experimentally, as well as in clinically confirmed cases. Experimental infection of cats with a SARS-CoV-2 isolate originating from Wuhan indicated that the cats are permissive to the infection, since the virus was able to replicate in the nose and throat and caused inflammatory pathology in the lower respiratory tract . Cases of naturally infected cats with clinical signs of mild-to-moderate severity have been reported in Belgium, the USA, Spain, France and Brazil (Carlos et al., 2021; de Morais et al., 2020; Sailleau et al., 2020; Segalés et al., 2020) . The clinical signs that have been described in cases involve mainly respiratory symptoms, such as breathing difficulty and cough. Gastrointestinal symptoms have also been reported (de Morais et al., 2020; Sailleau et al., 2020) . In a single case, the developed signs were severe, leading to euthanasia, although postmortem examination implicated SARS-CoV-2-unrelated hypertrophic cardiomyopathy with secondary thrombosis as the major cause of death (Segalés et al., 2020) .

Reports for the detection of SARS-CoV-2 or antibodies specifically directed against this virus in asymptomatic cats also exist. A serological investigation which took place in Wuhan during early 2020 revealed detection of virus-specific antibodies in naturally infected cats . A more recent study which took place in Italian households indicates that cats can seroconvert under the normal conditions of pet ownership (Patterson et al., 2020) . SARS-CoV-2 RNA was detected in the oral cavity, nasal and rectal swab samples obtained from a clinically healthy cat in Hong Kong (Abdel-Moneim & Abdelwhab, 2020) . However, the number of reports available for natural infection of cats within house environments is limited and, albeit the airborne virus transmission between infected and susceptible cats, has been experimentally demonstrated, the role of this host species in the natural transmission of SARS-CoV-2 remains unclear.

Since data currently available for natural infection of cats are scarce, the present study aims to investigate the course of SARS-CoV-2 infection in naturally exposed cats in a small household setting, in Greece. The owner of the animals was affected by and was in continuous close proximity with three cats, during the days corresponding to high virus shedding and the quarantine period. Serial samplings were conducted from the cats, to determine the onset and duration of infection and viral shedding, as well as their antiviral humoural immune responses. In order to be able to detect introductions of known variants and/or any emerged and adapted variants, and to obtain a preliminary understanding of the directionality of the chain of virus transmission, whole SARS-CoV-2 genomes from the cats and their owner were sequenced and subjected to molecular characterization and quasispecies analysis.

One day after the confirmation of the diagnosis (D5), one of the cats, an 11-year-old neutered female (Cat #1; C1), showed mild signs of self-limiting diarrhoea for 3 days, without exhibiting any other symptoms. Given the COVID-19 infection status of the owner, this cat and the other two (Cat #2; C2: a 10-year-old neutered male and Cat #3; C3: a 10-year-old neutered female) that were living in the same environment and did not experience clinical signs were subjected to clinical examination and laboratory investigations for SARS-CoV-2 infection.

On D16, all cats were clinically evaluated in detail in their household environment, and blood samples were obtained for haematology and serum biochemistry. Complete blood counts (ADVIA® 120 hematology system; Siemens Healthcare Diagnostics, Eschborn, Germany), including 100-cell manual differential leucocyte counts and evaluation for platelet aggregates, along with comprehensive blood serum biochemistry analysis (Vitalab Flexor E ; Vital Scientific N.V., Spankeren/Dieren, The Netherlands) were performed for each cat.

Oropharyngeal and faecal swabs were collected from the cats at various time-points, to identify the period of viral shedding ( Figure 1 ). All samples were obtained by means of 14.5-cm snappable sterile polystyrene/Dacron swabs (Deltalab, Barcelona, Spain).

Immediately after sample collection, the swab tips were being placed in 2-mL microcentrifuge tubes containing 800 μl of guanidinium isothiocyanate-based 'Lysis buffer I'. Lysates were subjected to a phenol-chloroform-based RNA extraction process coupled with silica column binding (Chaintoutis et al., 2019) .

All swabs obtained from the 3 cats at all time-points were tested for the presence of SARS-CoV-2 genome, via 2 separate real-time RT-PCR assays proposed as suitable for the laboratory diagnosis of COVID-19 in humans by international agencies.

Specifically, the protocol proposed by the European Centre for Disease Prevention and Control (ECDC) for the amplification of the genomic region that encodes the E protein was used . Similarly, the N2 method targeting the genomic region that encodes the N protein, which is proposed by the Centers for 

Quality control of the reads was performed within the Torrent Server of the sequencer, using the default settings. Reads were aligned using the bwa-mem v. 0.7.17-r1188 aligner ). The complete genome sequence of the 'Wuhan-Hu-1' SARS-CoV-2 isolate, GenBank Acc. No. NC_045512 was used as a reference. The aligned reads were subjected to both reference-guided assembly and variant calling.

Through the SAMtools software , the % coverage on the reference sequence and the mean sequencing depth were calculated. In order to further identify differences that may point a direction of the chain of the transmission, quasispecies analysis was performed. The LoFreq v.2.1.4 software (Wilm et al., 2012) was used to identify low-frequency variants (quasispecies) present in the sequenced samples, since it is able to detect variants that exist in a few aligned reads, while evaluating those based on quality metrics (cut-off p = .01). Due to the fact that the SARS-CoV-2 genome contains long stretches of homopolymers, quasispecies analysis was focussed on single nucleotide polymorphisms (SNPs).

SnpEff v.4.5covid19 (Cingolani et al., 2012) was used for annotation of variants, so as to be assigned to a specific viral protein.

SnpEff utilizes a genomic feature file (gff) that contains all the information on the viral protein structure and intervals on the reference sequence. The positions of non-synonymous (missense) variants were plotted onto the viral genome. The multiple sequence alignment was computed through Clustal Omega (Sievers & Higgins, 2014) , using the default parameters.

The phylogenetic tree encompassing European and Europeanrelated international isolates was implemented through the NextStrain platform (Hadfield et al., 2018) . Tree calculations were based on the maximum-likelihood method, with branch size taking into consideration temporal data (Price et al., 2010) . Branch colours represent GISAID clade annotation, while branch names on the tree are the NextStrain clades (Bogner et al., 2006; Hadfield et al., 2018) .

Lineage assignment was achieved via the Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) SARS-CoV-2 lineage assigner interface .

Serum samples were being collected at specific time-points from all cats for detection of SARS-CoV-2-specific antibodies (Figure 1 ). For this reason, the cats were mildly sedated with the alpha-2 adrenoceptor agonist dexmedetomidine (10 μg/kg, im). Approximately 40 min after administration and once the procedures were completed, sedation was rapidly reversed by the administration of the specific alpha-2 adrenoceptor antagonist, atipamezol (100 μg/kg, im).

Antigen Multi-species ELISA (ID.vet, Montpellier, France) kit was used. The antigen in this immunological assay is the N protein of SARS-CoV-2, and its format enables the detection of SARS-CoV-2specific antibodies in the tested sera, irrespective of their isotype.

Testing was performed following the manufacturer's instructions. 

On D16, all cats and were found bright, alert and responsive, with no cardiorespiratory signs (including upper respiratory signs) and normal temperature. According to the owner, their clinical condition remained unaltered throughout the observation period. Haematology and serum biochemistry findings were unremarkable (Table 1) Log 10 RNA copies/swab were determined on D7. A considerably lower virus titre (3.94 Log 10 RNA copies/swab) was measured on D10. During the subsequent 3 days, a slightly increasing viral load was measured (4.61, 4.83 and 5.48 Log 10 RNA copies/swab, respectively) in this animal's pharynx, and it finally tested negative on D14.

The oropharyngeal swab obtained from C3 on D7 was also characterized by a high viral load (8.42 Log 10 RNA copies/swab). However, differences were observed in the kinetics of SARS-CoV-2 presence in the upper respiratory tract of this animal, since steadily declining virus titres were measured between D10 and D13 (7.55, 6.72, 4.13 and 4.07 Log 10 RNA copies/swab, respectively). All subsequently collected swabs tested negative.

Faecal swabs obtained from C2 tested positive on the first day of sampling (D7, 5.31 Log 10 RNA copies/swab) and up to D11 with progressively declining virus titres (3.89 Log 10 RNA copies/swab).

Faecal swabs collected on D12 (i.e. 5 days after the first real-time RT-PCR-positive faecal swab) tested negative. Regarding C3, the kinetics of viral RNA concentrations in the faecal swabs was similar to that in its pharynx, although characterized by a time lag (Figure 1) .

A virus titre of 4.05 Log 10 RNA copies/swab was measured on D7.

Subsequently, a peak was observed on D9 (6.63 Log 10 RNA copies/ On D70, an S/P% of 217.6% was observed, indicating a decline in the respective SARS-CoV-2-specific serum antibody titre.

NGS processing yielded SARS-CoV-2 sequences for both C2 and C3 in oropharyngeal and faecal swabs, as well as in the oropharyngeal swab from the owner (Table 2 ). Multiple sequence alignment revealed an absolute overlap of amino-acid sequences. Only one difference among 5 samples was observed, a synonymous T-to-C SNP in position 24544 in the oropharyngeal sample of C3, at a ratio of 0.57 (Table 3) .

A statistically significant imbalance of quasispecies abundance at the aforementioned nucleotide position was observed among samples.

Specifically, the oropharyngeal swab of C3 showed an increased C variant ratio compared to the faecal swab of the same cat (Odds ratio: 11.96, p < .0001), since the presence of this variant in the faecal sample of this animal was also revealed, but the respective ratio was low (0.10). This variant was also identified in the owner's pharyngeal swab at an even lower ratio (0.07). Comparison with the oropharyngeal swab of C3 revealed an odds ratio of 17.72 (p < .0001). On the contrary, this variant was not identified neither in the oropharyngeal swab, nor the faecal swab from C2 and comparison with the oropharyngeal swab of C3 revealed an odds ratio of 1,061.57 (p < .0001). Two other sites (nucleotide positions 22685 and 23335) showed within-sample T/C variability in at least one additional sample (Table 3) .

Comparison of the sequence obtained from the oropharyngeal swab of C3 against the 'Wuhan-Hu-1' reference isolate indicated 17

SNPs (Table 4) 

Cats are popular companion animals in close contact with humans, and therefore, it is important to gain insight into their susceptibility 

a Nucleotide change not verified in the faecal swab of C2 due to reduced depth. (Gaudreault et al., 2020; Shi et al., 2020) , as well as the limited reports of clinically affected cats around the globe, indicating that following exposure to SARS-CoV-2, cats are not invariably infected, and when infection is established, the course is mostly asymptomatic. Cats may thus be silent hosts of SARS-CoV-2, as they may not show any appreciable symptoms that might be recognized by their owners . It is possible that the outcome in companion animals may depend on several factors, such as the proximity of contact with humans shedding high viral loads, possible co-morbidities, increased susceptibility to the virus (e.g. age-dependent), or a combination of these factors (de Morais et al., 2020; Shi et al., 2020) .

It has been reported that infected cats shed the virus for no more than 5 days following exposure (Bosco-Lauth et al., 2020; Shi et al., 2020) . The fact that viral RNA was detected in the pharynx of both infected cats of the present study, from D7 until D13, indicates that some cats may have a more prolonged shedding period.

Interestingly, serological testing of C2 against SARS-CoV-2 was negative at all sampling time-points. As previously suggested for infected humans, the absence of seroconversion may be indicative of mild infections involving only the respiratory mucosa, where secretory immune responses dominate, in conjunction with limited systemic IgG production (Staines et al., 2020) . For this reason, the amount of virus-specific secretory IgA in the respiratory mucosa could serve as an indicator of immune response in humans and in susceptible animal species (Chao et al., 2020) . Another possible explanation for this condition is that exposure to SARS-CoV-2 can

induce T-cell-mediated virus-specific responses, without seroconversion, similar to what has been suggested for humans (Gallais et al., 2020; Staines et al., 2020) . The fact that C2 did not seroconvert to SARS-CoV-2 may account for the continued presence of the virus in its pharynx, in low titres with a slightly increasing pattern (D10-D13), after the initial decline which was observed between D7 and D10. CoV-2 titres as high as ~10 5 viral RNA copies/g were measured in the faeces of experimentally infected and exposed cats . In contrast to the aforementioned observations, the detection period of SARS-CoV-2 in the faecal swabs obtained from C3 of the present study was over 6 days long. The course of viral RNA concentrations in faecal swabs of this animal seemed to reflect the course in the oropharyngeal swabs, with a peak virus titre of ~6.5 Log 10 viral RNA copies/swab being measured on D9 (i.e. 2 days after the first real-time RT-PCR-positive faecal swab). A similar SARS-CoV-2 titre kinetics pattern in stool compared to sputum has been observed symptomatic COVID-19

human patients (Wölfel et al., 2020) . However, despite the fact that the observed virus titres in the stool of human patients ex- Coronaviruses are capable of adapting quickly to new hosts through the processes of genetic recombination and mutation in vivo (Boni et al., 2020; Sironi et al., 2020) . in agreement with reports available so far that denote the humanto-feline transmission of the virus. Evidence-based support in favour of a cat-to-human SARS-CoV-2 transmission is not currently available, and this specific report does not match the essential criteria to demonstrate cat-to-human transmission (de Morais et al., 2020; Totton et al., 2020) .

The absolute overlap of amino-acid sequences among the sequenced viral strains signifies the absence of emergence of crossspecies adaptive mutations. In a previous experimental infection study, SARS-CoV-2 variants possessing the S-H655Y amino-acid substitution have been reported to rapidly arise and become fixed following transmission between cats, suggesting that this site may be under positive selection in feline hosts (Braun et al., 2020) .

This substitution was not found in any of the cat samples which were sequenced in the present study. The S-D614G amino-acid substitution was present, which is characteristic of the GISAID G and G-related clades and has been reported extensively in the past, as linked to increased SARS-CoV-2 infectivity and transmissibility (Hou et al., 2020) . This substitution, along with the aminoacid substitution NSP12-P323L, which was also identified herein, has been previously retrieved from human isolates originating from all continents of the earth and seem to co-evolve (Coppée et al., 2020) . The rare variant S-V1104L was also identified in the present report. This amino-acid substitution has occurred independently before, in isolates belonging to three other B1 Results further support previous observations indicating that companion animals are not easily infected by SARS-CoV-2, even when they are in close contact with infected owners (Temmam et al., 2020) . Additionally, our findings highlight difficulties in spontaneous cat-to-cat SARS-CoV-2 transmission, given that C1 was in continuous proximity to C2 and C3 during the peak of the viral shedding from them. The difficulty in cat-to-cat transmission is also supported by the findings of the previously discussed experimental infection/transmission study . The S-D614G amino-acid, which was identified in the viral strains of the present study, has been linked with increased SARS-CoV-2 replication in the upper airway of hamsters, suggesting its possible role in viral transmissibility (Plante et al., 2020) . However, despite the prolonged contact of C1 with the other two infected cats and their owner, this cat remained uninfected.

In conclusion, the present study comprises the first report of SARS-CoV-2 natural infection of cats in Greece. The owner acted as a source of the virus for the animals, as COVID-19 symptoms started one week before the first detection of the virus in the cats, confirming once again the reverse zoonotic character of SARS-CoV-2 transmission. Our results support the notion that human SARS-CoV-2 strains are relatively well-adapted to cats, despite the absence of emergence of cross-species adaptive mutations. It is still unclear whether the asymptomatic animals could play a role in COVID-19 epidemiology, in case of interaction with naïve animals and/or people. Both infected cats and their owner were not able to transmit the virus to a third cat living in the same place, despite their very close contact and the high SARS-CoV-2 titres measured in the pharynx of the infected cats on the first sampling timepoint. It remains to be elucidated whether infected cats shed infective virus to the environment, and until then, keeping infected cats inside is a reasonable suggestion. Besides the risk of possible transmission of SARS-CoV-2 from infected cats to humans, it is advisable for COVID-19 patients or asymptomatic virus carriers to avoid contact with cats, in order to minimize the possibilities of infecting them.

No potential conflicts of interest that could influence the results of the study exist.

The procedures described were performed according to The Code of Ethics of the World Medical Association (Declaration of Helsinki).

Informed consent was obtained for performing NGS analysis on the human specimen. The relevant study was approved by the Ethics Committee of the Department of Medicine, Democritus University of Thrace.

The nucleotide sequence of the strain "hCoV-19/cat/ Greece/2K/2020" is available at GISAID (EPI_ISL_717979).

Serafeim C. Chaintoutis https://orcid. org/0000-0003-1539-8237

Chrysostomos I. Dovas https://orcid.org/0000-0003-2947-1765

Evidence for SARS-CoV-2 infection of animal hosts

A global initiative on sharing avian flu data

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats

Transmission of SARS-CoV-2 in 1 domestic cats imposes a narrow 2 bottleneck 3

First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America

CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel

A PCR-based NGS protocol for whole genome sequencing of West Nile virus lineage 2 directly from biological specimens

Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections

The role of IgA in COVID-19

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3

Severe acute respiratory syndrome coronavirus 2: Virus mutations in specific European populations

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Natural Infection by SARS-CoV-2 in companion animals: A review of case reports and current evidence of their role in the epidemiology of COVID-19

SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus

Feline coronavirus in multicat environments

SARS-CoV-2 infection, disease and transmission in domestic cats

NextStrain: Realtime tracking of pathogen evolution

Transmission of SARS-CoV-2 in domestic cats

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

The architecture of SARS-CoV-2 transcriptome

Fast and accurate short read alignment with Burrows-Wheeler transform

The Sequence alignment/map format and SAMtools

Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection

Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy

Spike mutation D614G alters SARS-CoV-2 fitness

FastTree 2 -Approximately maximum-likelihood trees for large alignments

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

First detection and genome sequencing of SARS-CoV-2 in an infected cat in France

Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

Clustal omega

SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective

Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

How could we conclude cat-to-human transmission of SARS-CoV-2?

Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus

LoFreq: A sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

Virological assessment of hospitalized patients with COVID-2019

A new coronavirus associated with human respiratory disease in China

A serological survey of SARS-CoV-2 in cat in Wuhan

Limited cross-species transmission and absence of mutations associated with SARS-CoV-2 adaptation in cats: A case study of infection in a small household setting